About
Drug Store News
Products
and Services
|
Generics
Actavis' generic Strattera gets OK from FDAMORRISTOWN, N.J.
(Sept.
2)
The Food and Drug Administration has approved a generic drug made by Actavis for treating attention deficit hyperactivity disorder, Actavis said Wednesday. The FDA approved the drug maker’s atomoxetine hydrochloride capsules in the 10-mg, 18-mg, 25-mg, 40-mg, 60-mg, 80-mg and 100-mg strengths. The drug is a generic version of Eli Lilly’s Strattera, which had $532 million in sales during the 12-month period ended in June, according to IMS Health. Actavis has not yet set a launch date for the drug, as the U.S. Court of Appeals for the Federal Circuit is reviewing an Aug. 12 ruling that invalidated Lilly’s patent on the drug, which will expire in 2017. |
Teva markets AcuDial genericNORTH WALES, Pa.
(Sept.
2)
Teva Pharmaceuticals has launched a generic treatment for epileptic seizures. The world’s largest generic drug maker announced Wednesday the launch of diazepam rectal gel, a generic version of Valeant Pharmaceuticals’ Diastat AcuDial. The drug is administered via rectal syringe and is available in 2.5-mg, 10-mg and 20-mg strengths. “Generic pharmaceuticals are playing an increasingly important role in healthcare cost containment,” Teva VP customer operations and marketing Maureen Cavanaugh said. “Teva Pharmaceuticals continues to lead the way with timely new product launches.” |
FDA approves Sun's generic StratteraMUMBAI, India
(Sept.
1)
A generic drug maker has received regulatory approval for its version of an attention deficit hyperactivity disorder treatment. Sun Pharmaceutical Industries' subsidiary has received approval to market its generic version of Strattera (atomoxetine hydrochloride capsules), an ADHD drug for children ages 6 years and older, as well as teens and adults. Strattera is made and marketed by Eli Lilly. Annual sales of branded and generic atomoxetine hydrochloride capsules are estimated to be more than $530 million. |
MORE Generics
HEADLINES
Thursday, September 2
Wednesday, September 1
Tuesday, August 31
Friday, August 27
Thursday, August 26
Tuesday, August 24
more news
|
|
|